NRG Oncology

NRG-BR003

NCT02488967

Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer

Status:

Recruiting

26459-200.png

III

Phase

Line of Therapy.png

Adjuvant

Line of Therapy

Disease Stage.png

Early Cancer

Disease Stage

Target.png

Biomarker(s)

TNBC

Investigational

Product

carboplatin

Treatment Arms

o AC-->WP

o AC-->WP + carboplatin